Matthew Strobeck - 24 May 2024 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Role
Director
Signature
/s/ Phillip S. Askim, attorney-in-fact for Matthew Strobeck
Issuer symbol
QDEL
Transactions as of
24 May 2024
Net transactions value
$0
Form type
4
Filing time
29 May 2024, 16:41:20 UTC
Previous filing
23 May 2024
Next filing
06 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Award $0 +2,416 +23% $0.000000 12,846 24 May 2024 Direct F1
holding QDEL Common Stock 16,630 24 May 2024 UGMA Account F2
holding QDEL Common Stock 38,145 24 May 2024 Birchview F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Restricted Stock Units (Equity Grant) Options Exercise $0 -2,416 -100% $0.000000* 0 24 May 2024 Common Stock 2,416 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects release of restricted stock units that were previously reported on a Form 4.
F2 The Reporting Person is custodian under the Uniform Gift to Minor Act of 16,630 shares held by four of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of these shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 The Reporting Person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC in his capacity as the Managing Partner of such entity. The Reporting Person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F5 The restricted stock units vested on May 24, 2024.